Literature DB >> 17574770

Vitamin D status modulates the immune response to Epstein Barr virus: Synergistic effect of risk factors in multiple sclerosis.

Trygve Holmøy1.   

Abstract

MS risk is associated with low vitamin D status prior to disease, and Epstein Barr virus (EBV) infection seems to be a prerequisite for MS. EBV could activate autoreactive T cells by several mechanisms, but it is not clear why this leads to MS. Only a small proportion of those infected with EBV develops MS, whereas autoreactive T cells are present in the normal T cell repertoire. Genetic factors cannot explain this enigma alone, because the genetic predisposition to MS in most cases is quite weak. Vitamin D receptors are expressed on EBV infected B cells, antigen presenting cells and activated lymphocytes, and the bioactive vitamin D metabolite dihydroxyvitamin D(3) suppresses antibody production and T cell proliferation and skews T cells towards a less detrimental Th2 phenotype. EBV infected B cells constitute a constant challenge to the immune system, also during seasonal periods of relative low vitamin D status. I propose that vitamin D modulates the immune response to EBV, and that detrimental activation of autoreactive T cells leading to MS is more likely if the vitamin D status is suboptimal.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17574770     DOI: 10.1016/j.mehy.2007.04.030

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  17 in total

1.  Aetiology: Neighbourhood watch.

Authors:  Carolyn Brown
Journal:  Nature       Date:  2016-11-30       Impact factor: 49.962

2.  The possible roles of solar ultraviolet-B radiation and vitamin D in reducing case-fatality rates from the 1918-1919 influenza pandemic in the United States.

Authors:  William B Grant; Edward Giovannucci
Journal:  Dermatoendocrinol       Date:  2009-07

3.  Epidemiologic evidence supporting the role of maternal vitamin D deficiency as a risk factor for the development of infantile autism.

Authors:  William B Grant; Connie M Soles
Journal:  Dermatoendocrinol       Date:  2009-07

4.  Relation between Epstein-Barr virus and multiple sclerosis: analytic study of scientific production.

Authors:  O Santiago; J Gutierrez; A Sorlozano; J de Dios Luna; E Villegas; O Fernandez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-04-29       Impact factor: 3.267

Review 5.  Epstein-Barr virus in multiple sclerosis.

Authors:  Bridget A Bagert
Journal:  Curr Neurol Neurosci Rep       Date:  2009-09       Impact factor: 5.081

6.  Vitamin D status and antibody levels to common viruses in pediatric-onset multiple sclerosis.

Authors:  Ellen M Mowry; Judith A James; Lauren B Krupp; Emmanuelle Waubant
Journal:  Mult Scler       Date:  2011-01-06       Impact factor: 6.312

Review 7.  Vitamin D and multiple sclerosis: epidemiology, immunology, and genetics.

Authors:  Kelly C Simon; Kassandra L Munger; Alberto Ascherio
Journal:  Curr Opin Neurol       Date:  2012-06       Impact factor: 5.710

Review 8.  Environmental factors and their timing in adult-onset multiple sclerosis.

Authors:  Adam E Handel; Gavin Giovannoni; George C Ebers; Sreeram V Ramagopalan
Journal:  Nat Rev Neurol       Date:  2010-02-16       Impact factor: 42.937

9.  Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.

Authors:  Charles Pierrot-Deseilligny; Jean-Claude Souberbielle
Journal:  Ther Adv Neurol Disord       Date:  2013-03       Impact factor: 6.570

Review 10.  Clinical implications of a possible role of vitamin D in multiple sclerosis.

Authors:  Charles Pierrot-Deseilligny
Journal:  J Neurol       Date:  2009-04-28       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.